
Urinary liver-type fatty acid-binding protein in clinically healthy elderly cats : evaluation of its potential to detect IRIS stage 1 chronic kidney disease and borderline proteinuria
- Author
- Thirawut Kongtasai, Dominique Paepe (UGent) , Femke Mortier (UGent) , Sofie Marynissen (UGent) , Evelyne Meyer (UGent) , Luc Duchateau (UGent) and Sylvie Daminet (UGent)
- Organization
- Abstract
- Background: Urinary liver-type fatty acid-binding protein (uL-FABP) is a promising biomarker to detect early chronic kidney disease (CKD) in cats. Few healthy cats show increased uL-FABP for unknown reasons. Objectives: The objective of this study was to evaluate uL-FABP in a large healthy elderly cat population comparing cats with and without International Renal Interest Society (IRIS) stage 1 CKD and with and without borderline proteinuria. Methods: This was a cross-sectional study. One hundred ninety-six clinically healthy client-owned cats of >= 7 years old were subdivided based on two criteria: (1) having either IRIS stage 1 CKD or no evidence of CKD and (2) having borderline proteinuria or no proteinuria. Urinary L-FABP was measured using a validated commercially available feline L-FABP ELISA. Results: Overall, uL-FABP was detectable in 6/196 (3%) healthy elderly cats. For the first subdivision, nine (5%) cats had IRIS stage 1 CKD, 184 cats had no evidence CKD and three cats were excluded. All cats with IRIS stage 1 CKD had uL-FABP concentrations below the detection limit, whereas 6/184 (3%) cats without IRIS stage 1 CKD had detectable uL-FABP concentrations (median 1.79 ng/ml, range 0.79-3.66 ng/ml). For the second subdivision, 47 (24%) cats had borderline proteinuria, 147 cats had no proteinuria and two cats were excluded. One of the borderline proteinuric cats had a detectable uL-FABP concentration, whereas the other five cats with detectable uL-FABP concentrations were non-proteinuric. Conclusion: With the current assay, the screening potential of uL-FABP as an early biomarker for feline CKD is limited as uL-FABP was rarely detected in clinically healthy elderly cats independently of the presence of either IRIS stage 1 CKD or borderline proteinuria.
- Keywords
- GLOMERULAR-FILTRATION-RATE, L-FABP, BIOMARKERS, MARKERS, CREATININE, EXCRETION, DIAGNOSIS, INJURY, ESRD, renal biomarker, aged cats, screening, feline CKD
Downloads
-
Veterinary Medicine Sci - 2022 - Kongtasai - Urinary liver‐type fatty acid‐binding protein in clinically healthy elderly.pdf
- full text (Published version)
- |
- open access
- |
- |
- 724.39 KB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-01GRR66RDV1GDA0CVV1FH4TA2H
- MLA
- Kongtasai, Thirawut, et al. “Urinary Liver-Type Fatty Acid-Binding Protein in Clinically Healthy Elderly Cats : Evaluation of Its Potential to Detect IRIS Stage 1 Chronic Kidney Disease and Borderline Proteinuria.” VETERINARY MEDICINE AND SCIENCE, vol. 9, no. 1, Wiley, 2023, pp. 3–12, doi:10.1002/vms3.1003.
- APA
- Kongtasai, T., Paepe, D., Mortier, F., Marynissen, S., Meyer, E., Duchateau, L., & Daminet, S. (2023). Urinary liver-type fatty acid-binding protein in clinically healthy elderly cats : evaluation of its potential to detect IRIS stage 1 chronic kidney disease and borderline proteinuria. VETERINARY MEDICINE AND SCIENCE, 9(1), 3–12. https://doi.org/10.1002/vms3.1003
- Chicago author-date
- Kongtasai, Thirawut, Dominique Paepe, Femke Mortier, Sofie Marynissen, Evelyne Meyer, Luc Duchateau, and Sylvie Daminet. 2023. “Urinary Liver-Type Fatty Acid-Binding Protein in Clinically Healthy Elderly Cats : Evaluation of Its Potential to Detect IRIS Stage 1 Chronic Kidney Disease and Borderline Proteinuria.” VETERINARY MEDICINE AND SCIENCE 9 (1): 3–12. https://doi.org/10.1002/vms3.1003.
- Chicago author-date (all authors)
- Kongtasai, Thirawut, Dominique Paepe, Femke Mortier, Sofie Marynissen, Evelyne Meyer, Luc Duchateau, and Sylvie Daminet. 2023. “Urinary Liver-Type Fatty Acid-Binding Protein in Clinically Healthy Elderly Cats : Evaluation of Its Potential to Detect IRIS Stage 1 Chronic Kidney Disease and Borderline Proteinuria.” VETERINARY MEDICINE AND SCIENCE 9 (1): 3–12. doi:10.1002/vms3.1003.
- Vancouver
- 1.Kongtasai T, Paepe D, Mortier F, Marynissen S, Meyer E, Duchateau L, et al. Urinary liver-type fatty acid-binding protein in clinically healthy elderly cats : evaluation of its potential to detect IRIS stage 1 chronic kidney disease and borderline proteinuria. VETERINARY MEDICINE AND SCIENCE. 2023;9(1):3–12.
- IEEE
- [1]T. Kongtasai et al., “Urinary liver-type fatty acid-binding protein in clinically healthy elderly cats : evaluation of its potential to detect IRIS stage 1 chronic kidney disease and borderline proteinuria,” VETERINARY MEDICINE AND SCIENCE, vol. 9, no. 1, pp. 3–12, 2023.
@article{01GRR66RDV1GDA0CVV1FH4TA2H, abstract = {{Background: Urinary liver-type fatty acid-binding protein (uL-FABP) is a promising biomarker to detect early chronic kidney disease (CKD) in cats. Few healthy cats show increased uL-FABP for unknown reasons. Objectives: The objective of this study was to evaluate uL-FABP in a large healthy elderly cat population comparing cats with and without International Renal Interest Society (IRIS) stage 1 CKD and with and without borderline proteinuria. Methods: This was a cross-sectional study. One hundred ninety-six clinically healthy client-owned cats of >= 7 years old were subdivided based on two criteria: (1) having either IRIS stage 1 CKD or no evidence of CKD and (2) having borderline proteinuria or no proteinuria. Urinary L-FABP was measured using a validated commercially available feline L-FABP ELISA. Results: Overall, uL-FABP was detectable in 6/196 (3%) healthy elderly cats. For the first subdivision, nine (5%) cats had IRIS stage 1 CKD, 184 cats had no evidence CKD and three cats were excluded. All cats with IRIS stage 1 CKD had uL-FABP concentrations below the detection limit, whereas 6/184 (3%) cats without IRIS stage 1 CKD had detectable uL-FABP concentrations (median 1.79 ng/ml, range 0.79-3.66 ng/ml). For the second subdivision, 47 (24%) cats had borderline proteinuria, 147 cats had no proteinuria and two cats were excluded. One of the borderline proteinuric cats had a detectable uL-FABP concentration, whereas the other five cats with detectable uL-FABP concentrations were non-proteinuric. Conclusion: With the current assay, the screening potential of uL-FABP as an early biomarker for feline CKD is limited as uL-FABP was rarely detected in clinically healthy elderly cats independently of the presence of either IRIS stage 1 CKD or borderline proteinuria.}}, author = {{Kongtasai, Thirawut and Paepe, Dominique and Mortier, Femke and Marynissen, Sofie and Meyer, Evelyne and Duchateau, Luc and Daminet, Sylvie}}, issn = {{2053-1095}}, journal = {{VETERINARY MEDICINE AND SCIENCE}}, keywords = {{GLOMERULAR-FILTRATION-RATE,L-FABP,BIOMARKERS,MARKERS,CREATININE,EXCRETION,DIAGNOSIS,INJURY,ESRD,renal biomarker,aged cats,screening,feline CKD}}, language = {{eng}}, number = {{1}}, pages = {{3--12}}, publisher = {{Wiley}}, title = {{Urinary liver-type fatty acid-binding protein in clinically healthy elderly cats : evaluation of its potential to detect IRIS stage 1 chronic kidney disease and borderline proteinuria}}, url = {{http://doi.org/10.1002/vms3.1003}}, volume = {{9}}, year = {{2023}}, }
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: